The application deadline for the Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease is approaching.
The Chan Zuckerberg Initiative (CZI) invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. This RFA aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases that will clarify cellular mechanisms of disease, understand disease heterogeneity, and improve biomarker identification or diagnostics.
The awards cover $2 million in total costs for four years for each project, distributed among research institutions and a patient organization. Applications are due May 24, 2022 at 5 p.m. Pacific Time. Full details here.
Questions? Email [email protected].
